Search Results

The SmartLog Diabetes Management Software is PC-based software for use with the i-SENS blood glucose meters. The SmartLog Diabetes Management Software is intended for use in the home and professional settings to belp people with diabetes and their healthcare professionals in the review, and evaluation of glucose test results for an effective diabetes management program. The Smarti of Diabetes Management Software allows the user to download Blood glucose readings automatically from the meter to the PC.

The SmartLog Diabetes Management Software is an optional data management software for use only with the i-SENS brand of Blood Glucose Meters ("i-SENS Blood Glucose Meters") except CareSens POP and CareSens N Mini. The SmartLog Diabetes Management Software allows the transfer of data from the i-SENS Blood Glucose Meters to a personal computer for enhanced data management using graphic displays and analysis tools of the device. Various graphic analysis tools in this software help users of i-SENS BGM system easily analyze the trends and changes in their blood glucose.

Here's an analysis of the acceptance criteria and study information for the SmartLog Diabetes Management Software, based on the provided text:

Device Name: SmartLog Diabetes Management Software
510(k) Number: K13346

1. Acceptance Criteria and Reported Device Performance

The provided document, a 510(k) summary, focuses on demonstrating substantial equivalence to a predicate device rather than explicitly stating quantitative acceptance criteria for device performance. The "acceptance criteria" for this type of submission are implicitly that the new device performs at least as well as the predicate device across the functions it shares and that new features do not introduce safety or effectiveness concerns.

The study described is largely focused on software validation and data accuracy transmission. Here's a table summarizing the reported "performance" in the context of the validation activities mentioned:

• Setup Test
• End Test Download Reading Test
• Data Management Test
• User Profile Test
• Manual Entry Test
• Print Test
• Email Test
• Consumer Study
• Human Factors Study
  (The summary concludes substantial equivalence, implying these tests were passed successfully and the software performs as intended for its stated use. Specific pass/fail criteria or quantitative results for these individual tests are not detailed in this summary.) |
  | Substantial Equivalence to Predicate | The candidate device (SmartLog Diabetes Management Software) was found to be substantially equivalent to the predicate device (PC care Blood Glucose Data Management Software, K100937). This is the overarching acceptance criterion for a 510(k) submission. |

2. Sample Size Used for the Test Set and Data Provenance

• Sample Size for Test Set: The document does not specify a numerical sample size for the "test set." It broadly refers to "each meter" when discussing data accuracy transmission.
• Data Provenance: The document does not explicitly state the country of origin or whether the data was retrospective or prospective for the validation studies. The submitter is based in Korea.

3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

The document does not mention the use of experts to establish ground truth for the software validation tests. The "ground truth" for data transmission accuracy would likely be the data stored directly on the i-SENS blood glucose meters themselves, which the software is designed to download.

4. Adjudication Method for the Test Set

The document does not describe any adjudication method (e.g., 2+1, 3+1, none). Given the nature of the software (data management and display) and the validation activities (software functionality and data transmission), adjudication by multiple experts is not typically applicable in the same way it would be for diagnostic AI algorithms analyzing medical images.

5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done

No, an MRMC comparative effectiveness study was not done or described. This type of study is relevant for diagnostic devices where human readers interpret results, often with and without AI assistance. The SmartLog Diabetes Management Software is a data management tool, not a diagnostic interpretation AI.

6. If a Standalone (Algorithm Only Without Human-in-the-Loop Performance) Was Done

The software itself is standalone in the sense that it operates as an algorithm on a PC/Mac to manage and display data from blood glucose meters. The "validation activities" listed (Setup Test, Download Reading Test, Data Management Test, etc.) inherently represent tests of its standalone functionality, albeit without specific performance metrics (like sensitivity/specificity for a diagnostic AI). The "Consumer Study" and "Human Factors Study" do involve human interaction, but the core function of data processing is algorithmic. However, this is not an "algorithm-only" performance study in the typical sense used for complex diagnostic algorithms.

7. The Type of Ground Truth Used

The implicit "ground truth" for the data accuracy transmission tests would be the raw data exactly as stored on the i-SENS blood glucose meters. For the functional tests (e.g., "Print Test," "Email Test"), the ground truth would be the expected successful completion of the action and the correct output.

8. The Sample Size for the Training Set

The document does not mention a "training set" or its sample size. This device is a data management software, not a machine learning model that requires a training set. Its functionality is based on programming logic to import, organize, and display existing glucose data, rather than learning patterns from a dataset.

9. How the Ground Truth for the Training Set Was Established

As there is no mention of a training set, there is no description of how its ground truth was established.

Ask a specific question about this device